CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Open-market sale See Remarks sold 16,667 shares at $7.45 ($124,147)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale See Remarks sold 15,000 shares at $8.00 ($120,000)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Open-market sale See Remarks sold 24,907 shares at $7.08 ($176,257)
- 4 Planned sale See Remarks sold 16,667 shares at $7.43 ($123,776)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 135,400 shares at $7.22 ($977,019)
- 4 Planned sale Director sold 15,000 shares at $7.09 ($106,415)
- 144 Insider Sale of Securities
- 4 Planned sale See Remarks sold 16,667 shares at $7.01 ($116,781)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale See Remarks sold 23,242 shares at $7.46 ($173,402)
- 4 Planned sale See Remarks sold 16,667 shares at $7.40 ($123,296)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes See Remarks gave up 733 shares (to pay taxes)
Page 5 of 18 · 346 filings